← Pacira BioSciences, Inc.
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Net Income (Loss) Attributable to Parent | ($37.9m) |
($42.6m)
-12.28%
|
($471k)
+98.89%
|
($11.0m)
-2238.85%
|
$145.5m
+1421.01%
|
$42.0m
-71.15%
|
$15.9m
-62.10%
|
$42.0m
+163.72%
|
($99.6m)
-337.30%
|
$7.0m
+107.07%
|
— | |
| Depreciation, Depletion and Amortization | $12.9m | $13.8m | $13.2m | $19.6m | $19.9m | $28.5m | $91.5m | $75.6m | $78.8m | $91.0m | $85.2m | |
| Depreciation | $12.8m | $13.8m | $13.2m | $14.0m | $12.0m | $15.0m | $34.2m | $18.3m | $21.5m | $33.7m | $85.2m | |
| Amortization of Debt Issuance Costs | — | — | — | — | $2.2m | $2.8m | $4.4m | $3.0m | $3.1m | $2.8m | — | |
| Amortization of Debt Issuance Costs and Discounts | — | — | — | — | — | — | — | $3.7m | $3.2m | $3.0m | — | |
| Amortization of Intangible Assets | $100k | $0 | $13.2m | $5.7m | $7.9m | $13.6m | $57.3m | $57.3m | $57.3m | $57.3m | — | |
| Deferred Income Tax Expense (Benefit) | — | — | — | ($1.8m) | ($126.6m) | $10.9m | ($7.9m) | $15.6m | $20.6m | $6.5m | $10.0m | |
| Share-based Payment Arrangement, Noncash Expense | $31.2m | $31.6m | $31.7m | $33.6m | $39.9m | $42.2m | $48.1m | $47.9m | $51.2m | $57.5m | $56.0m | |
| Payment, Tax Withholding, Share-based Payment Arrangement | — | — | — | — | — | — | — | $106k | $491k | $5.6m | — | |
| Share-based Payment Arrangement, Expense | $31.2m | $31.6m | $31.7m | $33.6m | $39.9m | $42.2m | $48.1m | $47.9m | $51.2m | $57.5m | $56.0m | |
| Equity Method Investment, Other than Temporary Impairment | — | — | — | — | — | — | $10.0m | $0 | $0 | $11.0m | — | |
| Goodwill, Impairment Loss | — | — | — | — | — | — | — | — | $163.2m | $0 | $25.9m | |
| Impairment of Intangible Assets (Excluding Goodwill) | — | — | — | — | — | — | — | — | — | $25.9m | — | |
| Impairment of Intangible Assets, Indefinite-lived (Excluding Goodwill) | — | — | — | — | $0 | $0 | $26.1m | $0 | $0 | $25.9m | — | |
| Nonoperating Income (Expense) | ($5.8m) | ($17.5m) | ($16.3m) | ($21.2m) | ($26.3m) | ($33.5m) | ($46.7m) | ($26.0m) | — | ($2.3m) | — | |
| Other Nonoperating Income (Expense) | ($82k) | $167k | ($888k) | ($5.0m) | $2.9m | ($2.7m) | ($11.3m) | ($186k) | ($373k) | ($6.6m) | — | |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts Receivable | $4.1m | $1.7m | $6.0m | $8.5m | $5.5m | $10.4m | $2.1m | $7.2m | $7.7m | $10.7m | ($21.8m) | |
| Increase (Decrease) in Inventories | ($30.4m) | $10.1m | $7.2m | $8.0m | $6.4m | $4.5m | ($2.5m) | $8.3m | $20.9m | $27.6m | $3.8m | |
| Increase (Decrease) in Accounts Payable | — | — | ($573k) | ($1.8m) | ($3.3m) | ($10.3m) | $6.3m | $916k | $3.1m | ($5.6m) | ($12.7m) | |
| Net Cash Provided by (Used in) Operating Activities | $33.5m |
$17.8m
-46.84%
|
$48.9m
+174.78%
|
$70.5m
+44.30%
|
$77.0m
+9.23%
|
$125.7m
+63.20%
|
$145.3m
+15.56%
|
$154.6m
+6.45%
|
$189.4m
+22.46%
|
$152.0m
-19.75%
|
$187.7m
+23.47%
|
|
| Cash flows from investing activities: | ||||||||||||
| Payments to Acquire Property, Plant, and Equipment | $24.7m | $19.3m | $14.5m | $10.2m | $37.8m | $45.9m | $30.1m | $15.2m | $10.6m | $15.3m | ($8.1m) | |
| Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | ($389k) | ($2.1m) | ($65k) | ($1.0m) | ($22k) | $10k | ($193k) | — | — | — | $983k | |
| Gain (Loss) on Investments | — | — | ($854k) | ($4.3m) | $1.6m | ($2.7m) | — | — | — | — | — | |
| Payments to Acquire Investments | $192.8m | $502.8m | $363.3m | $318.5m | $546.5m | — | — | — | — | — | ($70.3m) | |
| Unrealized Gain (Loss) on Investments | — | — | — | $5.7m | — | — | — | — | — | — | — | |
| Payments to Acquire Businesses, Net of Cash Acquired | — | — | — | $117.7m | $0 | $0 | — | $0 | — | $16.7m | ($335k) | |
| Net Cash Provided by (Used in) Investing Activities | ($61.8m) | ($223.8m) | $20.6m | ($128.5m) | ($277.6m) | ($20.8m) | ($225.2m) | $77.5m | ($83.3m) | $99.5m | $94.1m | |
| Cash flows from financing activities: | ||||||||||||
| Gain (Loss) on Extinguishment of Debt | $0 | ($3.7m) | $0 | $0 | ($8.1m) | $0 | $0 | ($16.9m) | $7.5m | ($983k) | — | |
| Proceeds from Issuance of Long-term Debt | ($4k) | — | — | — | — | — | — | — | — | — | $0 | |
| Payments for Repurchase of Common Stock | — | — | — | — | — | — | — | — | $25.0m | $148.3m | — | |
| Net Cash Provided by (Used in) Financing Activities | $7.3m |
$224.2m
+2987.21%
|
$9.0m
-96.01%
|
$3.7m
-59.01%
|
$222.3m
+5957.33%
|
$380.7m
+71.25%
|
($401.5m)
-205.47%
|
($183.0m)
+54.42%
|
$17.4m
+109.49%
|
($369.6m)
-2228.82%
|
($376.2m)
-1.77%
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | — | — | — | — | $21.7m | $485.6m | ($481.4m) | $49.2m | $123.5m | ($118.2m) | $206.1m | |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | $104.1m | $153.3m | $276.8m | $158.5m | $206.1m | |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | — | — | — | — | — | — | — | $0 | $0 | ($77k) | ($243k) | |
| Additional Supplementary Disclosures | ||||||||||||
| Additional Supplementary Disclosures | ||||||||||||
| Proceeds from Stock Options Exercised | $5.8m | $6.8m | $7.2m | $8.5m | $45.2m | $23.8m | $24.4m | $1.9m | $0 | $502k | — | |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating Activities | $3.9m | $6.9m | $8.2m | $8.2m | $7.2m | $7.0m | $33.3m | $27.6m | $15.4m | $15.2m | — | |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | $9.0m | — | |
| Additional Financial Items | ||||||||||||
| Asset Retirement Obligation, Accretion Expense | — | $100k | $100k | $200k | $100k | — | — | — | — | — | — | |
| Gain (Loss) on Termination of Lease | — | — | — | — | — | — | — | — | ($2.2m) | $0 | — | |
| Goodwill | $46.7m | $55.2m | $62.0m | $99.5m | $99.5m | $145.2m | $163.2m | $163.2m | $0 | $20.2m | $25.9m | |
| Income Tax Expense (Benefit) | $105k | $140k | $46k | $268k | ($125.4m) | $14.4m | ($2.6m) | $19.7m | $36.5m | $9.8m | — | |
| Interest Expense Nonoperating | — | — | — | — | — | — | — | — | $16.6m | $17.4m | — | |
| Investment Income, Interest | $1.3m | $4.1m | $6.5m | $7.4m | $4.6m | $896k | $4.5m | $11.4m | $19.7m | $22.7m | — | |
| Litigation Settlement Loss | — | — | — | — | — | — | — | — | — | $7.0m | — | |
| Operating Expenses | $308.4m | $311.6m | $321.4m | $410.5m | — | — | — | — | — | — | — | |
| Realized Investment Gains (Losses) | — | — | $900k | — | — | — | — | — | — | — | — |